ZSAN

Zosano Pharma (ZSAN)

Zosano Pharma Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ZSAN

<< 이전 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2017/10/06	06:40	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/10/06	06:28	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/10/04	22:11	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/10/04	22:00	GlobeNewswire Inc.	Zosano Appoints Kenneth Greathouse to Board of Directors	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/09/27	06:03	GlobeNewswire Inc.	Zosano Provides Patent Application Update	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/09/14	00:36	GlobeNewswire Inc.	Zosano Presents Data from ZOTRIP Study at International Headache Society	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/08/28	21:30	GlobeNewswire Inc.	Zosano Pharma Announces US Patent Office Publication of “Method of Rapidly Achieving Therapeutic Concentrations of Triptans...	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/08/24	06:06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/08/12	08:19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/08/11	05:35	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/08/11	05:18	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/08/11	05:01	GlobeNewswire Inc.	Zosano Pharma Reports Second Quarter 2017 Financial Results and Operational Update	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/08/02	21:30	GlobeNewswire Inc.	Zosano Pharma to Host Conference Call on Second Quarter 2017 Financial Results and Provide Operational Update	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/07/31	22:30	GlobeNewswire Inc.	Zosano Announces Publication of Positive Phase 1 Data of Zolmitriptan Delivery In Future Medicine’s Pain Management Journal...	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/06/26	21:30	GlobeNewswire Inc.	Zosano Pharma Announces Outcome of End of Phase 2 Meetings with FDA	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/06/15	05:01	GlobeNewswire Inc.	Zosano Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/06/12	21:30	GlobeNewswire Inc.	Zosano Presents Additional Data from ZOTRIP Study at American Headache Society, Demonstrating Positive Results for Pain Freed...	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/06/10	05:08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/06/06	05:33	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/06/06	05:29	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/06/01	21:30	GlobeNewswire Inc.	Zosano to Present Migraine Data at Three Industry-Leading Conferences	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/05/27	06:55	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/05/25	05:12	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/05/23	07:27	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/05/10	06:16	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/05/10	05:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/05/10	05:00	GlobeNewswire Inc.	Zosano Reports First Quarter 2017 Financial Results and Announces Management Changes	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/05/09	07:14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/05/08	18:30	GlobeNewswire Inc.	Zosano Pharma to Host Conference Call on First Quarter 2017 Financial Results and Provide Operational Update	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/05/06	06:21	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation